Want to see SG:V8Y full AI Analyst Report?
Top Page
Quantum Healthcare Ltd.
(SGX:V8Y)
Select Model
Select Model
Rating:42Neutral
Price Target:―
Action:Reiterated
Date:08/19/26
The score is primarily weighed down by weak profitability and a fragile balance sheet with persistent negative equity, despite improving revenue momentum and recently positive operating/free cash flow. Limited valuation support (negative P/E due to losses) and unavailable technical signals keep the overall assessment cautious.
Positive Factors
Revenue Growth
Strong TTM revenue growth indicates improving demand and market traction. If sustained, the larger revenue base could help Quantum Healthcare absorb fixed costs and move toward operating profitability over the next several quarters.
Negative Factors
Negative Shareholders’ Equity
Persistent negative equity materially weakens financial flexibility and leaves the capital structure fragile. It can restrict access to financing, increase refinancing risk, and make the company more vulnerable to operating setbacks until equity is rebuilt.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Strong TTM revenue growth indicates improving demand and market traction. If sustained, the larger revenue base could help Quantum Healthcare absorb fixed costs and move toward operating profitability over the next several quarters.
Read all positive factors
Quantum Healthcare Ltd. (V8Y) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$12.59M
Dividend YieldN/A
Average Volume (3M)N/A
Price to Earnings (P/E)―
Beta (1Y)-5.27
Revenue Growth2.08%
EPS Growth-50.00%
CountrySG
Employees92
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding12,587,903,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-5.44
Price to Sales (P/S)0.63
P/FCF Ratio4.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Quantum Healthcare Ltd. Business Overview & Revenue Model
Company Description
Quantum Healthcare Limited, a Singapore-based enterprise established in 2005, specializes in the design, assembly, and commercialization of sophisticated therapeutic solutions for the minimally invasive management of intricate vascular diseases. T...
Quantum Healthcare Ltd. Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
22
Negative
Cash Flow
56
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.21M | 13.06M | 12.69M | 13.08M | 9.37M | 0.00 |
| Gross Profit | 5.94M | 5.93M | 5.66M | 5.76M | 4.35M | -246.00K |
| EBITDA | -841.00K | -686.00K | -318.00K | -1.45M | -7.23M | -5.03M |
| Net Income | -2.76M | -2.74M | -2.23M | -3.62M | -9.07M | -5.28M |
Balance Sheet | ||||||
| Total Assets | 10.42M | 10.79M | 12.53M | 13.03M | 14.45M | 916.00K |
| Cash, Cash Equivalents and Short-Term Investments | 1.56M | 2.59M | 386.00K | 744.00K | 5.07M | 344.00K |
| Total Debt | 3.87M | 4.18M | 7.64M | 6.51M | 7.55M | 997.00K |
| Total Liabilities | 11.72M | 11.85M | 15.50M | 16.06M | 15.35M | 3.55M |
| Stockholders Equity | -1.83M | -1.52M | -3.62M | -3.87M | -1.50M | -2.59M |
Cash Flow | ||||||
| Free Cash Flow | 941.00K | 1.89M | 1.09M | -926.00K | -2.23M | -964.23K |
| Operating Cash Flow | 999.00K | 1.94M | 1.45M | -628.00K | -1.30M | -964.23K |
| Investing Cash Flow | -46.00K | -38.00K | -1.07M | -3.42M | -5.04M | 59.89K |
| Financing Cash Flow | 412.00K | 419.00K | -733.00K | -272.00K | 11.06M | 177.47K |
Quantum Healthcare Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
SG:V8Y
Quantum Healthcare Ltd.
―
―
―
SG:BSL
Raffles Medical Group
0.86
-0.13
-13.55%
SG:A50
Thomson Medical Group Ltd.
0.05
>-0.01
-8.47%
SG:1D4
Aoxin Q&M Dental Group Ltd.
0.20
0.14
251.79%
SG:40T
ISEC Healthcare Ltd
0.32
-0.04
-10.76%
SG:505
Asiamedic Limited
0.02
0.00
0.00%
Quantum Healthcare Ltd. Corporate Events
Quantum Healthcare reallocates placement funds and issues secured S$600,000 promissory note
Jun 23, 2026
Quantum Healthcare has updated investors on the use of S$3 million raised through a placement of over 2.7 billion new shares, indicating that S$855,000 has been spent on working capital such as directors’ fees, salaries, professional and adm...
Quantum Healthcare AGM backs board, renews capital and buy-back mandates
May 28, 2026
Quantum Healthcare Ltd. reported that all resolutions at its fourth annual general meeting were passed by poll with unanimous support from shareholders present or by proxy. Shareholders adopted the audited financial statements for the year ended 3...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.